T. Rowe Price Associates
SLGCW

T. Rowe Price Associates’s SomaLogic, Inc. Warrant SLGCW Stock Holding History

T. Rowe Price Associates’s Portfolio SLGCW Stock Details SLGCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-110,347
Closed -$14K – 3011
2023
Q4 		$14K Hold
110,347
– – ﹤0.01% 2883
2023
Q3 		$25K Sell
110,347
-1,353
-1% -$332 ﹤0.01% 2843
2023
Q2 		$28K Sell
111,700
-4,970
-4% -$1.79K ﹤0.01% 2853
2023
Q1 		$32K Sell
116,670
-6,566
-5% -$2.89K ﹤0.01% 2828
2022
Q4 		$49K Sell
123,236
-6,989
-5% -$2.78K ﹤0.01% 2813
2022
Q3 		$58K Sell
130,225
-544
-0.4% -$362 ﹤0.01% 2813
2022
Q2 		$99K Hold
130,769
– – ﹤0.01% 2757
2022
Q1 		$267K Sell
130,769
-200,682
-61% -$486K ﹤0.01% 2596
2021
Q4 		$1.11M Sell
331,451
-6
-0% -$23 ﹤0.01% 1979
2021
Q3 		$1.14M Buy
+331,457
New +$1.02M ﹤0.01% 1991

Other funds holding SLGCW

GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

T. Rowe Price Associates's SLGCW Position: Q1 2024 in Review

T. Rowe Price Associates sold out of SomaLogic, Inc. Warrant (SLGCW) in Q1 2024, closing a stake of 110,347 shares — an estimated $14K sold.

T. Rowe Price Associates first reported a position in SLGCW in Q3 2021 and held it in 10 quarters. The position peaked at $1.14M in Q3 2021. 4 funds tracked by Wall St. Rank hold SLGCW as of Q1 2024.

  • T. Rowe Price Associates reported no remaining SomaLogic, Inc. Warrant position as of Q1 2024 after selling out during the quarter.
  • T. Rowe Price Associates sold 110,347 SomaLogic, Inc. Warrant shares in Q1 2024, an estimated $14K.
  • T. Rowe Price Associates first reported a position in SomaLogic, Inc. Warrant in Q3 2021 and held it in 10 quarters.
  • T. Rowe Price Associates's SomaLogic, Inc. Warrant position peaked at $1.14M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held SomaLogic, Inc. Warrant as of Q1 2024.

Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.